How much do GLP-1s cost without insurance?

The sticker prices ($1,349 Wegovy, $1,086 Zepbound list) are negotiating fictions of the U.S. drug system; here’s what cash payers actually pay: | Option | Typical monthly | What you get | | --- | --- | --- | | Zepbound vials (LillyDirect) | ≈$349–$499 | Brand tirzepatide, syringe-drawn from vials | | Wegovy (NovoCare direct) | ≈$499 | Brand semaglutide pens shipped to you | | Compounded semaglutide (telehealth) | ≈$199–$399 | Non-brand; prescriber visits often bundled | | Compounded tirzepatide (telehealth) | ≈$250–$450 | Non-brand; visits often bundled | | Sublingual compounded forms | ≈$200–$400 | Needle-free; evidence caveats | | Generic liraglutide | often under $300 | Daily shots, ≈8% loss — the budget floor | Hidden math worth running: - Dose changes the bill on vial-priced and many compounded programs — higher maintenance doses cost more, which makes “lowest effective dose” a financial strategy as well as a clinical one, and makes maintenance microdosing materially cheaper than loss-phase dosing. - Count the whole subscription: visit fees, shipping, mandatory “memberships,” add-on products. A $249 program with $75 of mandatory extras loses to a transparent $299. Comparison shopping among the established telehealth programs —, NexLife. - HSA/FSA dollars work for prescriptions and telehealth fees — a ≈20–30% effective discount for many. - Timeline honesty: treatment runs 12–18 months to goal plus maintenance, so the real question is annual: roughly $2,400–$6,000/year cash depending on route. Against that, the insurance fight — appeals included — is often worth more per hour than anything else on this page. The one corner never worth cutting: “$99 semaglutide, no prescription” is not a price tier, it’s a scam category.